TAK | Takeda Pharmaceutical Co Ltd Category: Consumer goods Industry: Drug Manufacturers - Specialty & Generic Quick infos Headquarters: Tokyo, Japan Trade prices Volume: Market Cap: 43.76B Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: Next ER: July 28, 2023
Date EPS / Forecast Revenue / Forecast October 26, 2023 July 27, 2023 0.2049 / 0.1418 7.54B / 7.12B Beat! May 11, 2023 0.074 / 0.0505 7.07B / 7.16B February 2, 2023 0.2927 / 0.2838 8.37B / 7.45B Beat! October 27, 2022 0.1345 / 0.1336 6.79B / 6.78B Beat! view more
News Sippican Capital Advisors Buys Coterra Energy Inc, DaVita Inc, Physicians Realty Trust, Sells ... finance.yahoo.com Jul 21, 2022 1:38 pm Seagen (SGEN) Q4 Earnings Miss, Revenues Top Mark, Stock Down finance.yahoo.com Jul 21, 2022 12:42 pm Denali (DNLI) Q4 Loss Wider Than Expected, Revenues Lag finance.yahoo.com Jul 21, 2022 11:36 am 10 Cheap Pharmaceutical Stocks For 2022 finance.yahoo.com Jul 21, 2022 10:14 am Veriti Management LLC Buys Aluminum Corporation of China, EPAM Systems Inc, United ... finance.yahoo.com Jul 21, 2022 9:38 am Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and Beyond fool.com Jul 21, 2022 8:05 am Takeda Announces U.S. Corporate Social Responsibility (CSR) Program Aimed to Help Reduce Social Disparities finance.yahoo.com Jul 21, 2022 8:00 am Takeda Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluating HYQVIA® for Maintenance Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) finance.yahoo.com Jul 21, 2022 8:00 am Takeda to Acquire Adaptate Biotherapeutics to Develop Novel Gamma Delta () T Cell Engager Therapies Targeting Solid Tumors finance.yahoo.com Jul 21, 2022 7:00 am Takeda eyeing early 2022 rollout of Novavax's COVID-19 shot in Japan -CEO finance.yahoo.com Jul 21, 2022 5:34 am Biomanufacturing startup discloses another $1.2B in venture funding bizjournals.com Jul 21, 2022 5:22 am Moderna and Takeda Announce Plans to Transfer Marketing Authorization for Spikevax(TM) COVID-19 Vaccine in Japan to Moderna finance.yahoo.com Jul 21, 2022 3:40 am UPDATE 1-Japan approves Moderna COVID vaccine as booster, Novavax files for 1st approval finance.yahoo.com Jul 21, 2022 12:11 am Novavax asks for FDA meeting after first global authorization for COVID-19 vaccine: CEO finance.yahoo.com Jul 20, 2022 2:10 pm HilleVax, a Biopharma Developing Vaccines, Is Going Public barrons.com Jul 20, 2022 1:00 pm 14 Stocks to Buy According to Daniel Kims Blackcrane Capital finance.yahoo.com Jul 20, 2022 12:14 pm Takeda Canada applauds Quebec's new Rare Disease Policy finance.yahoo.com Jul 20, 2022 11:00 am Beech Hill Advisors, Inc. Buys Block Inc, The Walt Disney Co, Activision Blizzard Inc, Sells ... finance.yahoo.com Jul 20, 2022 9:38 am 10 Dividend Stocks to Buy According to Billionaire Steve Cohen finance.yahoo.com Jul 20, 2022 9:01 am UPDATE 1-Takeda eyeing early 2022 rollout of Novavax's COVID-19 shot in Japan - CEO finance.yahoo.com Jul 20, 2022 8:07 am Key Persons CEO : Christophe Weber (1 Apr 2015–), Christophe Weber (Apr 2015–) Talk about Takeda Pharmaceutical Co Ltd below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
If you are looking for News & events, Press Release, they are available on their Investors Relationssite.
If you want to help pay for server cost or for improving this tool. You can send it via
Paypal. More features coming soon :) Buy on Amazon
While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.